The only previous report linking CRAT to AR demonstrated that CRAT expression and activity are higher in AR-positive PC3 and LNCaP prostate cancer cells compared to AR-negative PNT2 cells (56) but did not perturb AR to demonstrate a causal relationship between AR and CRAT expression. This evidence concerns the gene AR and prostate carcinoma.